CHSI Catalyst Health Solutions, Inc featured news, full reports, and detailed charts
Catalyst Health Solutions, Inc (CHSI) Wrap Up:
The following description of our business should be read in conjunction with the information included elsewhere in this Form 10-K for the year ended December 31, 2007. This description contains forward-looking statements that involve risks and uncertainties. Our actual results could differ significantly from the results discussed in the forward-looking statements due to the factors set forth in “Risk Factors” and elsewhere in this Form 10-K. References in this Form 10-K to “we,” “our,” “us,” or the “Company,” refer to HealthExtras, Inc. OVERVIEW HealthExtras, Inc. provides pharmacy benefit management services, referred to as PBM, and supplemental benefit programs. Our PBM segment, which operates primarily under the brand name Catalyst Rx, accounted for approximately 99%, 97% and 94% of our revenue in 2007, 2006 and 2005, respectively, and is expected to be the primary source of our growth and profits in the future. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f02%2f29%2f0001193125-08-043289.html#FIS_BUSINESS"Catalyst Health Solutions, Inc. (CHSI:NASDAQ)
Snapshot of Catalyst Health Solutions, Inc. (CHSI)
|
OPEN
$34.08
|
PREVIOUS CLOSE
$34.16
|
|
|
DAY HIGH
$34.45
|
DAY LOW
$34.00
|
|
|
52 WEEK HIGH
11/16/09 - $35.25
|
52 WEEK LOW
03/12/09 - $15.67
|
|
|
MARKET CAP
1.5B
|
AVERAGE VOLUME 3 mo
262.3K
|
|
|
DILUTED EPS TTM
$1.40
|
SHARES OUTSTANDING
44.2M
|
|
|
CHSI Does Not Pay Dividends
|
P/E TTM
24.4x
|
|
| K = Thousands M = Millions B = Billions | ||
CHSI Top Compensated Officers
Executives, Board Directors
Key developments for Catalyst Health Solutions, Inc. (CHSI)
Catalyst Health Solutions, Inc. expected to Report Fiscal Year 2009 Results on February 22, 2010. This event was calculated by Capital IQ (Created on November 4, 2009).
Catalyst Health Solutions, Inc. reported earnings results for the third quarter and nine months ended September 30, 2009. Revenue for the third quarter increased by $72.6 million, or 11.1%, to $725.6 million from $653.0 million in the prior year's comparable quarter. The increase in revenue is due to the increase in prescription volume and price inflation on brand drugs, offset by the impact of the increase in generic utilization. Third quarter operating income increased 43.0% to $27.9 million from $19.5 million in the third quarter of 2008. The increase in operating income was primarily due to the increase in gross profit, offset by a $2.9 million increase in selling, general and administrative expenses. Net income for the third quarter of 2009 was $17.2 million, or $0.39 per diluted share, compared to the prior year's net income of $12.6 million, or $0.29 per diluted share. Income before income taxes was $27.85 million compared to $20.19 million in the previous year period. For the nine months ended September 30, 2009, revenue increased 15.7%, to approximately $2.1 billion from $1.9 billion in the prior year. The increase in revenue is due to the increase in prescription volume and price inflation on brand drugs, offset by the impact of the increase in generic utilization. Operating income increased by $21.0 million to $75.5 million in the first nine months of 2009 from $54.5 million in the same period of the prior year. The increase in operating income was primarily due to the increase in gross profit offset by an $11.2 million increase in selling, general and administrative expenses. Net income for the first nine months of 2009 was $47.2 million, or $1.08 per diluted share, compared to $36.2 million, or $0.83 per diluted share in the prior year. Income before income taxes was $75.89 million compared to $58.22 million in the previous year period. The company expects 2010 net income to grow by approximately 25%. Net income for 2010 is projected between $81.0 million and $84.0 million, which equates to earnings per diluted share of $1.80 to $1.88 per share. Revenue in 2010 is projected between $3.3 billion and $3.6 billion. Total revenue will be directly impacted by the effective dates of new business wins.
Catalyst Health Solutions, Inc., Q3 2009 Earnings Call, Nov-04-2009
CHSI Competitors
| Company | Last | Change |
| CVS Caremark Corp | $31.64 USD | +0.56 |
| Express Scripts Inc | $85.09 USD | +1.05 |
| Medco Health Solutions Inc | $61.61 USD | +0.26 |
| SXC Health Solutions Corp | $49.68 USD | +0.08 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CHSI | Industry Range |
| Price/Earnings | 24.4x |
|
| Price/Sales | 0.5x |
|
| Price/Book | 3.6x |
|
| Price/Cash Flow | 24.6x |
|
| TEV/Sales | 0.5x |
|
|
CHSI |
||
CHSI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Catalyst Health Solutions, Inc
More news for CHSI
Catalyst Health Solutions, Inc. to Report Third Quarter Earnings Results on November 3, 2009
ROCKVILLE, Md.--(BUSINESS WIRE)--Catalyst Health Solutions, Inc. (NASDAQ:CHSI - News), a pharmacy benefit management company, will release its third quarter earnings results on Tuesday, November 3, 2009, after the market closes. The Company will hold a conference call on Wednesday, November 4, 2009, at 10:00 a.m. Eastern time. To participate, call 1-800-533-7954, access code 4329114 ten minutes prior to the scheduled start time, and request to be connected to the Catalyst Health Solutions Q3 Earnings Call.Following brief opening remarks, the conference call will be open for a question-and-answer session. The conference call will be available for telephonic replay from November 4, after 1:00 p.m. Eastern time, through November 14 at 1:00 p.m. Eastern time. To access the replay, dial 1-888-203-1112, replay access code 4329114.About Catalyst Health Solutions, Inc. (www.chsi.com):Catalyst Health Solutions, Inc. is built on strong, innovative principles in the management of prescription drug benefits and provides an unbiased, client-centered philosophy resulting in...Click here to read the whole Article (external link)
CATALYST HEALTH SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct
Show all filings for CATALYST HEALTH SOLUTIONS, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for CATALYST HEALTH SOLUTIONS, INC. 13-Oct-2009Entry into a Material Definitive Agreement, Creation of a Direct Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All i...Click here to read the whole Article (external link)
Q3 2009 Catalyst Health Solutions, Inc. Earnings Release - After Market Close
Earnings Announcements for Tuesday, November 3CompanySymbolTimeConferenceCall3D SystemsTDSCAfter Market CloseListenAbengoaABG.MC11:45 pm ETListenAcorda TherapeuticsACORBefore Market OpenListenAECON GROUP INCARE.TOAfter Market CloseAGA Medical Holdings, Inc.AGAMAfter Market CloseListenAllis-Chalmers Energy Inc.ALYBefore Market OpenAllos Therapeutics, Inc.ALTHAfter Market CloseListenAlpha Natural Resources, Inc.ANRBefore Market OpenAmerican Capital Ltd.ACASAfter Market CloseListenAmerican Tower Corp.AMT07:00 am ETListenAmeriSourceBergenABCBefore Market OpenListenAMICAS INCAMCSAfter Market CloseAMTRUST FINANCIAL SERVICES INCAFSIAfter Market CloseANIMAL HEALTH INTERNATIONAL INCAHIITime Not SuppliedAnoto Group ABAOTOF.PK02:30 am ETAnworth Mortgage Asset...Click here to read the whole Article (external link)
Catalyst Health Solutions Reports Record Earnings for Third Quarter 2009
 CATALYST HEALTH SOLUTIONS, INC. and Subsidiaries  CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited)     For the three months For the nine months ended September 30, ended September 30, 2009  2008 2009  2008 Revenue (excludes member co-payments of $206,441, $193,334, $598,744 and $557,924 for the three months and nine months ended September 30, 2009 and 2008, respectively) $ 725,579  $ ...Click here to read the whole Article (external link)
Catalyst Health earnings up 37%
ONLINE: home | business news | small business | sales & marketing | real estate | events | community | careers | city guide | advertise | about us | rss PRINT: subscribe | renew | advertise | book of lists | business intelligence | classifieds | ...Click here to read the whole Article (external link)
CATALYST HEALTH SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
Show all filings for CATALYST HEALTH SOLUTIONS, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for CATALYST HEALTH SOLUTIONS, INC. 4-Nov-2009Results of Operations and Financial Condition, Financial Statemen Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All infor...Click here to read the whole Article (external link)
New Star Analyst Rankings for Catalyst Health Solutions, Inc
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Copyright © 1999-2003, StarMine Corp. All rights reserved.StarMine Corp. derives analyst ratings from estimate and recommendation data supplied by Thomson Financial.Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and...Click here to read the whole Article (external link)
CATALYST HEALTH SOLUTIONS, INC. Financials
PERIOD ENDING30-Sep-0930-Jun-0931-Mar-0931-Dec-08Total Revenue725,579 717,629 703,272 687,400 Cost of Revenue676,612 672,494 662,142 647,120 Gross Profit48,967 45,135 41,130 40,280 Operating ExpensesResearch Development - - - - Selling General and Administrative21,102 19,262 19,319 19,365 Non Recurring - - - - Others - - - - Total Operating Expenses - - - - Operating Income or Loss27,865 25,873 21,811 20,915 Income from Continuing OperationsTotal Other Income/Expenses Net103 279 324 605 Earnings Before Interest And Taxes27,968 26,152 22,135 21,520 Interest Expense113 119 131 76 Income Before Tax27,855 26,033 22,004 21,444 Income Tax Expense10,625 9,876 8,186 7,264 Minority Interest - - - - Net Income From Continuing Ops17,230 16,157 13,818 14,180 Non-recurring EventsDiscontinued Operations - - - - Extraordinary Items - - ...Click here to read the whole Article (external link)
CATALYST HEALTH SOLUTIONS, INC. Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Quarterly Report on Form 10-Q may contain certain forward-looking statements, including without limitation, statements concerning Catalyst Health Solutions, Inc.'s operations, economic performance and financial condition. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. These forward-looking statements may include statements addressing our operations and our financial performance. Readers are cautioned not to place undue reliance on these forward-looking statements, which, among other things, speak only as of their dates. These forward-looking statements are based largely on Catalyst Health Solutions, Inc.'s current expectations and are subject to a number of risks and uncertainties. Factors we have identified that may materially affect our results are discussed in our Annual Report on Form 10-K for the year ended December 31, 2008, particularly under Item 1A, "Risk Factors", and in our other filings with the Securities and Exchange Commission. In addition, other important factors to consider in evaluating such forward-looking statements include changes in external market factors, changes in Catalyst Health Solutions, Inc.'s business or growth strategy or an inability to execute its strategy, including due to changes in its industry or the economy generally. In light of these risks and uncertainties, there...Click here to read the whole Article (external link)
